Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan (Tracleer) pilot study in active Behçet disease
NL-OMON26435Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Behçet's disease (BD) comparing Tracleer with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Oct 2008; status: active, not recruiting.
02
Drugs
bosentan
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on NL-OMON26435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26435.